hlx10
Showing 1 - 17 of 17
Adult Solid Tumor Trial (HLX26, HLX10)
Recruiting
- Adult Solid Tumor
- HLX26
- HLX10
-
Xuzhou, Jiangsu, ChinaXuzhou Central Hospital
Oct 17, 2022
Metastatic Colorectal Cancer Trial in China (HLX10/Placebo, HLX04/Avastin)
Active, not recruiting
- Metastatic Colorectal Cancer
- HLX10
- HLX04、
-
Guangzhou, Guangdong, China
- +3 more
Dec 19, 2022
Limited Stage Small Cell Lung Cancer Trial (HLX10, hypofractionated radiotherapy, Prophylactic Cranial Irradiation (PCI))
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- HLX10
- +2 more
- (no location specified)
Jun 29, 2022
Cervical Cancer Trial in Beijing (HLX10, Paclitaxel, Cisplatin)
Withdrawn
- Cervical Cancer
- HLX10
- +4 more
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
May 1, 2022
Extensive Stage Small Cell Lung Cancer Trial in Shanghai (HLX10, carboplatin and etoposide, )
Active, not recruiting
- Extensive Stage Small Cell Lung Cancer
- HLX10
- +2 more
-
Shanghai, China
- +5 more
Sep 28, 2022
Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in Guanzhou (HLX07, HLX10, )
Not yet recruiting
- Nasopharyngeal Carcinoma by AJCC V8 Stage
- HLX07
- +3 more
-
Guanzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 23, 2022
Small-cell Lung Cancer Trial in Changchun (HLX07, HLX10, carboplatin and etoposide)
Not yet recruiting
- Small-cell Lung Cancer
- HLX07
- +2 more
-
Changchun, Jilin, ChinaJilin Cancer Hospital
May 3, 2022
Advanced Hepatocellular Carcinoma Trial (HLX07, HLX10, HLX04)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- HLX07
- +3 more
- (no location specified)
May 1, 2022
MSI-H Solid Malignant Tumor Trial in China (HLX10)
Recruiting
- MSI-H Solid Malignant Tumor
- HLX10
-
Hefei, Anhui, China
- +32 more
Oct 26, 2022
Limited-Stage Small Cell Lung Cancer Trial in Jinan (HLX10, carboplatin/cisplatin-etoposide, Thoracic radiotherapy)
Recruiting
- Limited-Stage Small Cell Lung Cancer
- HLX10
- +4 more
-
Anaheim, California
- +83 more
Jan 12, 2023
Squamous Non Small Cell Lung Cancer Trial in Worldwide (HLX10, carboplatin and nab paclitaxel, Placebo)
Active, not recruiting
- Squamous Non Small Cell Lung Cancer
- HLX10
- +2 more
-
Roanoke, Virginia
- +91 more
Apr 25, 2022
Solid Tumor Trial in Taipei City (HLX10)
Unknown status
- Solid Tumor
- HLX10
-
Taipei City, TaiwanTaipei Municipal Wanfang Hospital
May 28, 2020
Triple Negative Breast Cancer Trial (HLX10, nab-paclitaxel, carboplatin, doxorubicin or epirubicin and cyclophosphamide,
Not yet recruiting
- Triple Negative Breast Cancer
- HLX10
- +2 more
- (no location specified)
Mar 10, 2020